Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	pheromone receptor activity	VN1R2 VN1R3 VN1R4 VN1R5	1.39e-08	6	112	4	GO:0016503
GeneOntologyMolecularFunction	G protein-coupled receptor activity	VN1R2 VN1R3 VN1R4 VN1R5 OR2A7 OR2T27 OR11G2 OR4K13 OR2T7 OR2T1 GPRC5C OR2T34 SSTR5 OR2T3 OR2A4 OR52N5 OR1P1 ADGRD2 OR6T1	4.46e-07	884	112	19	GO:0004930
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	VN1R2 VN1R3 VN1R4 VN1R5 OR2A7 OR2T27 OR11G2 OR4K13 OR2T7 OR2T1 GPRC5C OR2T34 PTCH1 SSTR5 OR2T3 BMPR2 OR2A4 TLR4 OR52N5 OR1P1 ADGRD2 OR6T1	5.24e-06	1353	112	22	GO:0004888
GeneOntologyMolecularFunction	olfactory receptor activity	OR2A7 OR2T27 OR11G2 OR4K13 OR2T7 OR2T1 OR2T34 OR2T3 OR2A4 OR52N5 OR1P1 OR6T1	5.53e-06	431	112	12	GO:0004984
GeneOntologyMolecularFunction	transporter activity	SLC25A20 TMC7 ABCC11 SLC13A3 SLC18B1 ABCA8 RYR3 SLC5A5 CNNM1 ATP8A1 CLCN2 MFSD14B SLCO2A1 NPC1L1 CACNA1I SLC5A12 SLC14A2 SLC4A9	2.90e-04	1289	112	18	GO:0005215
GeneOntologyMolecularFunction	transmembrane transporter activity	SLC25A20 TMC7 ABCC11 SLC13A3 SLC18B1 ABCA8 RYR3 SLC5A5 CNNM1 ATP8A1 CLCN2 MFSD14B SLCO2A1 CACNA1I SLC5A12 SLC14A2 SLC4A9	3.04e-04	1180	112	17	GO:0022857
GeneOntologyMolecularFunction	pheromone binding	VN1R2 VN1R4	3.08e-04	5	112	2	GO:0005550
GeneOntologyMolecularFunction	structural constituent of tooth enamel	AMELX AMELY	4.61e-04	6	112	2	GO:0030345
GeneOntologyMolecularFunction	hydroxyapatite binding	AMELX AMELY	8.54e-04	8	112	2	GO:0046848
GeneOntologyBiologicalProcess	sensory perception of chemical stimulus	VN1R2 VN1R3 VN1R4 VN1R5 OR2A7 OR2T27 OR11G2 OR4K13 OR2T7 OR2T1 OR2T34 ADCY3 OR2T3 OR2A4 OR52N5 OR1P1 OR6T1	4.90e-09	547	110	17	GO:0007606
GeneOntologyBiologicalProcess	response to pheromone	VN1R2 VN1R3 VN1R4 VN1R5	1.57e-07	10	110	4	GO:0019236
GeneOntologyBiologicalProcess	detection of chemical stimulus	OR2A7 OR2T27 OR11G2 OR4K13 OR2T7 OR2T1 TLR9 OR2T34 OR2T3 OR2A4 TLR4 OR52N5 OR1P1 OR6T1	7.73e-07	524	110	14	GO:0009593
GeneOntologyBiologicalProcess	sensory perception	VN1R2 VN1R3 VN1R4 VN1R5 OR2A7 OR2T27 OR11G2 OR4K13 OR2T7 OR2T1 GPRC5C OR2T34 ADCY3 OR2T3 OR2A4 TLR4 OR52N5 OR1P1 MAPK1 OR6T1	8.80e-07	1072	110	20	GO:0007600
GeneOntologyBiologicalProcess	G protein-coupled receptor signaling pathway	VN1R2 VN1R3 VN1R4 VN1R5 OR2A7 OR2T27 OR11G2 OR4K13 OR2T7 OR2T1 GPRC5C OR2T34 LMBRD2 SSTR5 ADCY3 OR2T3 PLPPR4 OR2A4 OR52N5 OR1P1 CCL4 ADGRD2 OR6T1	1.01e-06	1395	110	23	GO:0007186
GeneOntologyBiologicalProcess	sensory perception of smell	OR2A7 OR2T27 OR11G2 OR4K13 OR2T7 OR2T1 OR2T34 ADCY3 OR2T3 OR2A4 OR52N5 OR1P1 OR6T1	1.20e-06	465	110	13	GO:0007608
GeneOntologyBiologicalProcess	detection of chemical stimulus involved in sensory perception of smell	OR2A7 OR2T27 OR11G2 OR4K13 OR2T7 OR2T1 OR2T34 OR2T3 OR2A4 OR52N5 OR1P1 OR6T1	3.38e-06	432	110	12	GO:0050911
GeneOntologyBiologicalProcess	detection of chemical stimulus involved in sensory perception	OR2A7 OR2T27 OR11G2 OR4K13 OR2T7 OR2T1 OR2T34 OR2T3 OR2A4 OR52N5 OR1P1 OR6T1	1.09e-05	485	110	12	GO:0050907
GeneOntologyBiologicalProcess	detection of stimulus involved in sensory perception	OR2A7 OR2T27 OR11G2 OR4K13 OR2T7 OR2T1 OR2T34 OR2T3 OR2A4 TLR4 OR52N5 OR1P1 OR6T1	1.36e-05	582	110	13	GO:0050906
GeneOntologyBiologicalProcess	detection of stimulus	OR2A7 OR2T27 OR11G2 OR4K13 OR2T7 OR2T1 TLR9 OR2T34 OR2T3 OR2A4 TLR4 OR52N5 OR1P1 OR6T1	3.01e-05	722	110	14	GO:0051606
GeneOntologyBiologicalProcess	territorial aggressive behavior	NLGN4Y NLGN4X	8.43e-05	3	110	2	GO:0002124
GeneOntologyBiologicalProcess	synaptic vesicle endocytosis	NLGN4Y ACTB ACTG1 ATP8A1 NLGN4X	1.64e-04	96	110	5	GO:0048488
GeneOntologyBiologicalProcess	male courtship behavior	NLGN4Y NLGN4X	1.68e-04	4	110	2	GO:0008049
GeneOntologyBiologicalProcess	regulation of transepithelial transport	ACTB ACTG1	1.68e-04	4	110	2	GO:0150111
GeneOntologyBiologicalProcess	presynaptic endocytosis	NLGN4Y ACTB ACTG1 ATP8A1 NLGN4X	2.17e-04	102	110	5	GO:0140238
GeneOntologyBiologicalProcess	synaptic vesicle recycling	NLGN4Y ACTB ACTG1 ATP8A1 NLGN4X	3.22e-04	111	110	5	GO:0036465
GeneOntologyCellularComponent	basal plasma membrane	SLC13A3 TLR9 ABCA8 BMPR2 CLCN2 SLCO2A1 FLOT1 SLC14A2 SLC4A9	1.07e-04	354	110	9	GO:0009925
GeneOntologyCellularComponent	postsynaptic actin cytoskeleton	MYO9B ACTB ACTG1	1.29e-04	19	110	3	GO:0098871
GeneOntologyCellularComponent	symmetric, GABA-ergic, inhibitory synapse	NLGN4Y NLGN4X	1.64e-04	4	110	2	GO:0098983
GeneOntologyCellularComponent	basal part of cell	SLC13A3 TLR9 ABCA8 BMPR2 CLCN2 SLCO2A1 FLOT1 SLC14A2 SLC4A9	1.75e-04	378	110	9	GO:0045178
GeneOntologyCellularComponent	basolateral plasma membrane	SLC13A3 TLR9 ABCA8 CLCN2 SLCO2A1 FLOT1 SLC14A2 SLC4A9	2.93e-04	320	110	8	GO:0016323
GeneOntologyCellularComponent	postsynaptic cytoskeleton	MYO9B ACTB ACTG1	3.37e-04	26	110	3	GO:0099571
GeneOntologyCellularComponent	dense body	ACTB ACTG1	5.66e-04	7	110	2	GO:0097433
GeneOntologyCellularComponent	blood microparticle	ACTB ACTG1 ACTG2 CPN2 PZP	9.92e-04	144	110	5	GO:0072562
GeneOntologyCellularComponent	plasma membrane raft	PTCH1 BMPR2 TEX101 MAPK1 FLOT1	1.09e-03	147	110	5	GO:0044853
GeneOntologyCellularComponent	apical part of cell	ACTG1 ABCC11 TLR9 PTCH1 BMPR2 NPC1L1 SLC5A12 FLOT1 SLC14A2 SLC4A9	1.14e-03	592	110	10	GO:0045177
HumanPheno	Retinoschisis	ACTB ACTG1 CLCN2	1.36e-05	8	33	3	HP:0030502
MousePheno	short Tomes' process	AMELX AMELY	2.76e-05	2	74	2	MP:0030513
Domain	Vmron_rcpt_1	VN1R2 VN1R3 VN1R4 VN1R5	5.67e-09	5	110	4	IPR004072
Domain	V1R	VN1R2 VN1R3 VN1R4 VN1R5	5.67e-09	5	110	4	PF03402
Domain	ACTINS_1	ACTB ACTG1 ACTG2	1.09e-05	8	110	3	PS00406
Domain	G_PROTEIN_RECEP_F1_1	VN1R2 VN1R3 VN1R4 VN1R5 OR2A7 OR2T27 OR11G2 OR4K13 OR2T1 OR2T34 SSTR5 OR2T3 OR2A4 OR52N5 OR6T1	1.16e-05	685	110	15	PS00237
Domain	G_PROTEIN_RECEP_F1_2	VN1R2 VN1R3 VN1R4 VN1R5 OR2A7 OR2T27 OR11G2 OR4K13 OR2T1 OR2T34 SSTR5 OR2T3 OR2A4 OR52N5 OR6T1	1.29e-05	691	110	15	PS50262
Domain	GPCR_Rhodpsn	VN1R2 VN1R3 VN1R4 VN1R5 OR2A7 OR2T27 OR11G2 OR4K13 OR2T1 OR2T34 SSTR5 OR2T3 OR2A4 OR52N5 OR6T1	1.31e-05	692	110	15	IPR000276
Domain	NLGN4	NLGN4Y NLGN4X	3.44e-05	2	110	2	IPR030025
Domain	Amelogenin	AMELX AMELY	3.44e-05	2	110	2	SM00818
Domain	Amelogenin	AMELX AMELY	3.44e-05	2	110	2	PF02948
Domain	Amelogenin	AMELX AMELY	3.44e-05	2	110	2	IPR004116
Domain	Actin_CS	ACTB ACTG1 ACTG2	1.05e-04	16	110	3	IPR004001
Domain	Olfact_rcpt	OR2A7 OR2T27 OR11G2 OR4K13 OR2T1 OR2T34 OR2T3 OR2A4 OR52N5 OR6T1	1.10e-04	393	110	10	IPR000725
Domain	ACTINS_2	ACTB ACTG1 ACTG2	1.27e-04	17	110	3	PS00432
Domain	Actin/actin-like_CS	ACTB ACTG1 ACTG2	1.52e-04	18	110	3	IPR020902
Domain	GPCR_Rhodpsn_7TM	VN1R2 VN1R4 OR2A7 OR2T27 OR11G2 OR4K13 OR2T1 OR2T34 SSTR5 OR2T3 OR2A4 OR52N5 OR6T1	1.57e-04	670	110	13	IPR017452
Domain	SPRY	RFPL1 TRIM22 RYR3 BTN1A1 RFPL3	1.63e-04	87	110	5	SM00449
Domain	ACTINS_ACT_LIKE	ACTB ACTG1 ACTG2	1.80e-04	19	110	3	PS01132
Domain	SPRY	RFPL1 TRIM22 RYR3 BTN1A1 RFPL3	2.34e-04	94	110	5	PF00622
Domain	SPRY_dom	RFPL1 TRIM22 RYR3 BTN1A1 RFPL3	2.34e-04	94	110	5	IPR003877
Domain	B30.2/SPRY	RFPL1 TRIM22 RYR3 BTN1A1 RFPL3	2.46e-04	95	110	5	IPR001870
Domain	B302_SPRY	RFPL1 TRIM22 RYR3 BTN1A1 RFPL3	2.46e-04	95	110	5	PS50188
Domain	Nlgn	NLGN4Y NLGN4X	3.40e-04	5	110	2	IPR000460
Domain	RDM	RFPL1 RFPL3	3.40e-04	5	110	2	PF11002
Domain	RDM_domain_RFPL	RFPL1 RFPL3	3.40e-04	5	110	2	IPR022723
Domain	LON	LONRF1 LONRF2	5.08e-04	6	110	2	SM00464
Domain	LON_N	LONRF1 LONRF2	5.08e-04	6	110	2	PS51787
Domain	LON_substr-bd_dom	LONRF1 LONRF2	5.08e-04	6	110	2	IPR003111
Domain	LON_substr_bdg	LONRF1 LONRF2	5.08e-04	6	110	2	PF02190
Domain	Butyrophylin	RFPL1 TRIM22 BTN1A1 RFPL3	7.75e-04	70	110	4	IPR003879
Domain	Actin	ACTB ACTG1 ACTG2	7.92e-04	31	110	3	IPR004000
Domain	Actin	ACTB ACTG1 ACTG2	7.92e-04	31	110	3	PF00022
Domain	ACTIN	ACTB ACTG1 ACTG2	7.92e-04	31	110	3	SM00268
Domain	Znf-RING_LisH	LONRF1 TRIM22 LONRF2	1.04e-03	34	110	3	IPR027370
Domain	zf-RING_UBOX	LONRF1 TRIM22 LONRF2	1.04e-03	34	110	3	PF13445
Domain	Ptc/Disp	PTCH1 NPC1L1	1.20e-03	9	110	2	IPR003392
Domain	Patched	PTCH1 NPC1L1	1.20e-03	9	110	2	PF02460
Domain	NA_SOLUT_SYMP_1	SLC5A5 SLC5A12	1.83e-03	11	110	2	PS00456
Domain	-	MARS1 VARS1	1.83e-03	11	110	2	1.10.730.10
Domain	ConA-like_dom	RFPL1 TRIM22 RYR3 BTN1A1 ADGRD2 RFPL3	1.89e-03	219	110	6	IPR013320
Domain	PRY	RFPL1 BTN1A1 RFPL3	1.93e-03	42	110	3	PF13765
Domain	7tm_1	OR2A7 OR2T27 OR11G2 OR4K13 OR2T1 OR2T34 SSTR5 OR2T3 OR2A4 OR52N5 OR6T1	2.16e-03	677	110	11	PF00001
Domain	NA_SOLUT_SYMP_2	SLC5A5 SLC5A12	2.18e-03	12	110	2	PS00457
Domain	SSF	SLC5A5 SLC5A12	2.18e-03	12	110	2	PF00474
Domain	Na/solute_symporter	SLC5A5 SLC5A12	2.18e-03	12	110	2	IPR001734
Domain	NA_SOLUT_SYMP_3	SLC5A5 SLC5A12	2.18e-03	12	110	2	PS50283
Domain	SSD	PTCH1 NPC1L1	2.57e-03	13	110	2	IPR000731
Domain	SSD	PTCH1 NPC1L1	2.57e-03	13	110	2	PS50156
Domain	Carboxylesterase_B_CS	NLGN4Y NLGN4X	2.57e-03	13	110	2	IPR019819
Domain	PRY	RFPL1 BTN1A1 RFPL3	2.84e-03	48	110	3	SM00589
Domain	PRY	RFPL1 BTN1A1 RFPL3	2.84e-03	48	110	3	IPR006574
Domain	CARBOXYLESTERASE_B_2	NLGN4Y NLGN4X	2.99e-03	14	110	2	PS00941
Domain	COesterase	NLGN4Y NLGN4X	2.99e-03	14	110	2	PF00135
Domain	CarbesteraseB	NLGN4Y NLGN4X	2.99e-03	14	110	2	IPR002018
Domain	tRNAsynth_Ia_anticodon-bd	MARS1 VARS1	3.43e-03	15	110	2	IPR009080
Domain	CBS	CNNM1 CLCN2	3.91e-03	16	110	2	SM00116
Domain	aa-tRNA-synth_I_CS	MARS1 VARS1	4.95e-03	18	110	2	IPR001412
Domain	PUA-like_domain	LONRF1 LONRF2	5.51e-03	19	110	2	IPR015947
Domain	AA_TRNA_LIGASE_I	MARS1 VARS1	5.51e-03	19	110	2	PS00178
Domain	CBS_dom	CNNM1 CLCN2	6.09e-03	20	110	2	IPR000644
Pathway	REACTOME_OLFACTORY_SIGNALING_PATHWAY	OR2A7 OR2T27 OR11G2 OR4K13 OR2T7 OR2T1 OR2T34 ADCY3 OR2T3 OR2A4 OR52N5 OR1P1 OR6T1	1.35e-06	417	86	13	M4072
Pathway	REACTOME_SENSORY_PERCEPTION	OR2A7 OR2T27 OR11G2 OR4K13 OR2T7 ACTB ACTG1 OR2T1 OR2T34 ADCY3 OR2T3 OR2A4 OR52N5 OR1P1 OR6T1	6.14e-06	636	86	15	M41834
Pathway	KEGG_OLFACTORY_TRANSDUCTION	OR2A7 OR2T27 OR11G2 OR4K13 OR2T1 OR2T34 ADCY3 OR2T3 OR2A4 OR52N5 OR6T1	2.34e-05	389	86	11	M14091
Pathway	WP_GPCRS_OTHER	VN1R5 OR2A7 OR2T1 SSTR5 OR2A4 OR1P1	2.58e-05	96	86	6	MM15939
Pathway	WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION	ACTB ACTG1 ACTG2 MAPK1	1.10e-04	41	86	4	M39655
Pubmed	Novel human vomeronasal receptor-like genes reveal species-specific families.	VN1R2 VN1R3 VN1R4 VN1R5	1.06e-10	4	113	4	12123587
Pubmed	Evolutionary deterioration of the vomeronasal pheromone transduction pathway in catarrhine primates.	VN1R2 VN1R3 VN1R4 VN1R5	5.27e-10	5	113	4	12826614
Pubmed	Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins.	COL4A6 ACTB ACTG1 ACTG2 LAMB3	2.06e-08	26	113	5	24742657
Pubmed	Leucine-Rich Amelogenin Peptide (LRAP) Uptake by Cementoblast Requires Flotillin-1 Mediated Endocytosis.	AMELX AMELY FLOT1	3.34e-08	3	113	3	27277399
Pubmed	Regulating the functions of the HIV-1 matrix protein.	ACTB ACTG1 ACTG2 MAPK1	1.03e-07	14	113	4	17411366
Pubmed	JNK-interacting protein 3 associates with Toll-like receptor 4 and is involved in LPS-mediated JNK activation.	TLR9 MAPK8IP3 TLR4	1.33e-07	4	113	3	12941697
Pubmed	Multiple new and isolated families within the mouse superfamily of V1r vomeronasal receptors.	VN1R2 VN1R4 VN1R5	1.33e-07	4	113	3	11802169
Pubmed	Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein.	ACTB ACTG1 ACTG2	6.63e-07	6	113	3	9971772
Pubmed	Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin.	ACTB ACTG1 ACTG2	6.63e-07	6	113	3	10074138
Pubmed	Virus assembly and plasma membrane domains: which came first?	ACTB ACTG1 ACTG2	6.63e-07	6	113	3	22989508
Pubmed	HIV-1 protease cleaves actin during acute infection of human T-lymphocytes.	ACTB ACTG1 ACTG2	6.63e-07	6	113	3	1540415
Pubmed	HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility.	ACTB ACTG1 ACTG2	6.63e-07	6	113	3	11709093
Pubmed	Tagging the human immunodeficiency virus gag protein with green fluorescent protein. Minimal evidence for colocalisation with actin.	ACTB ACTG1 ACTG2	6.63e-07	6	113	3	10049817
Pubmed	Human immunodeficiency virus nucleocapsid protein polymorphisms modulate the infectivity of RNA packaging mutants.	ACTB ACTG1 ACTG2	6.63e-07	6	113	3	12009869
Pubmed	HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury.	ACTB ACTG1 ACTG2	6.63e-07	6	113	3	23811015
Pubmed	Retroviral assembly and budding occur through an actin-driven mechanism.	ACTB ACTG1 ACTG2	6.63e-07	6	113	3	19883584
Pubmed	Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells.	ACTB ACTG1 ACTG2	6.63e-07	6	113	3	21917091
Pubmed	HIV-1 Gag protein associates with F-actin present in microfilaments.	ACTB ACTG1 ACTG2	6.63e-07	6	113	3	8661406
Pubmed	A protein ballet around the viral genome orchestrated by HIV-1 reverse transcriptase leads to an architectural switch: from nucleocapsid-condensed RNA to Vpr-bridged DNA.	ACTB ACTG1 ACTG2	6.63e-07	6	113	3	23017337
Pubmed	Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens.	ACTB ACTG1 ACTG2	6.63e-07	6	113	3	23875777
Pubmed	Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton.	ACTB ACTG1 ACTG2	6.63e-07	6	113	3	9841925
Pubmed	The PDZ-adaptor protein syntenin-1 regulates HIV-1 entry.	ACTB ACTG1 ACTG2	1.16e-06	7	113	3	22535526
Pubmed	Selective targeting of ITK blocks multiple steps of HIV replication.	ACTB ACTG1 ACTG2	1.16e-06	7	113	3	18443296
Pubmed	The trinity of the cortical actin in the initiation of HIV-1 infection.	ACTB ACTG1 ACTG2	1.16e-06	7	113	3	22640593
Pubmed	HIV-1 replication from after cell entry to the nuclear periphery.	ACTB ACTG1 ACTG2	1.16e-06	7	113	3	17504171
Pubmed	siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-Tat.	ACTB ACTG1 ACTG2	1.16e-06	7	113	3	22465675
Pubmed	Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors.	VN1R2 VN1R4 VN1R5	1.16e-06	7	113	3	19387439
Pubmed	The human olfactory receptor gene family.	OR2A7 OR2T27 OR11G2 OR4K13 OR2T7 OR2T1 OR2T34 OR2A4 OR52N5 OR1P1 OR6T1	1.62e-06	541	113	11	14983052
Pubmed	Human immunodeficiency virus type 1 Tat regulates endothelial cell actin cytoskeletal dynamics through PAK1 activation and oxidant production.	ACTB ACTG1 ACTG2	1.85e-06	8	113	3	14694110
Pubmed	Lentiviral Nef proteins utilize PAK2-mediated deregulation of cofilin as a general strategy to interfere with actin remodeling.	ACTB ACTG1 ACTG2	1.85e-06	8	113	3	20147394
Pubmed	Interleukin 2-inducible T cell kinase (ITK) facilitates efficient egress of HIV-1 by coordinating Gag distribution and actin organization.	ACTB ACTG1 ACTG2	1.85e-06	8	113	3	23260110
Pubmed	Autoimmune amelogenesis imperfecta in patients with APS-1 and coeliac disease.	AMELX AMELY LAMB3	1.85e-06	8	113	3	37993717
Pubmed	Gene expression and dental enamel structure in developing mouse incisor.	AMELX AMELY ACTB ACTG2	2.36e-06	29	113	4	20487000
Pubmed	Clustering of vomeronasal receptor genes is required for transcriptional stability but not for choice.	VN1R2 VN1R4 VN1R5	2.77e-06	9	113	3	36383665
Pubmed	Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF.	ACTB ACTG1 ACTG2	2.77e-06	9	113	3	10556093
Pubmed	Cytoskeletal proteins inside human immunodeficiency virus type 1 virions.	ACTB ACTG1 ACTG2	2.77e-06	9	113	3	8892894
Pubmed	HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells.	ACTB ACTG1 ACTG2	2.77e-06	9	113	3	18775311
Pubmed	Actin, troponin C, Alzheimer amyloid precursor protein and pro-interleukin 1 beta as substrates of the protease from human immunodeficiency virus.	ACTB ACTG1 ACTG2	3.94e-06	10	113	3	1907279
Pubmed	Non-viral cellular substrates for human immunodeficiency virus type 1 protease.	ACTB ACTG1 ACTG2	3.94e-06	10	113	3	1991513
Pubmed	Gelsolin activity controls efficient early HIV-1 infection.	ACTB ACTG1 ACTG2	3.94e-06	10	113	3	23575248
Pubmed	A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs.	ACTB ACTG1 ACTG2 MAPK8IP3	5.12e-06	35	113	4	20946988
Pubmed	CAP2 deficiency delays myofibril actin cytoskeleton differentiation and disturbs skeletal muscle architecture and function.	ACTB ACTG1 ACTG2	5.41e-06	11	113	3	30962377
Pubmed	N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton.	ACTB ACTG1 ACTG2	5.41e-06	11	113	3	23294842
Pubmed	Toll-like receptors.	TLR9 TLR4 SLC14A2	5.41e-06	11	113	3	18394314
Pubmed	Quantitative proteomic analysis of lentiviral vectors using 2-DE.	ACTB ACTG1 ACTG2	5.41e-06	11	113	3	19639585
Pubmed	HIV-1 Nef impairs heterotrimeric G-protein signaling by targeting Gα(i2) for degradation through ubiquitination.	ACTB ACTG1 ACTG2	7.19e-06	12	113	3	23071112
Pubmed	Excess NF-κB induces ectopic odontogenesis in embryonic incisor epithelium.	AMELX AMELY PTCH1	9.33e-06	13	113	3	25376721
Pubmed	The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells.	TLR9 TLR4	1.05e-05	2	113	2	18092352
Pubmed	Beta- and gamma-cytoplasmic actins are required for meiosis in mouse oocytes.	ACTB ACTG1	1.05e-05	2	113	2	21778137
Pubmed	Amelogenin, the major protein of tooth enamel: a new phylogenetic marker for ordinal mammal relationships.	AMELX AMELY	1.05e-05	2	113	2	18346915
Pubmed	TLR-Stimulated Eosinophils Mediate Recruitment and Activation of NK Cells In Vivo.	TLR9 TLR4	1.05e-05	2	113	2	28426135
Pubmed	De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome.	ACTB ACTG1	1.05e-05	2	113	2	22366783
Pubmed	Molecular cloning and DNA sequence of rat amelogenin and a comparative analysis of mammalian amelogenin protein sequence divergence.	AMELX AMELY	1.05e-05	2	113	2	8297387
Pubmed	Human and mouse amelogenin gene loci are on the sex chromosomes.	AMELX AMELY	1.05e-05	2	113	2	2737677
Pubmed	Acquisition of adult-like TLR4 and TLR9 responses during the first year of life.	TLR9 TLR4	1.05e-05	2	113	2	20442853
Pubmed	Prenatal presentation and diagnosis of Baraitser-Winter syndrome using exome sequencing.	ACTB ACTG1	1.05e-05	2	113	2	32588558
Pubmed	A solution NMR investigation into the early events of amelogenin nanosphere self-assembly initiated with sodium chloride or calcium chloride.	AMELX AMELY	1.05e-05	2	113	2	19086270
Pubmed	Assessment of TLR4 and TLR9 signaling and correlation with human papillomavirus status and histopathologic parameters in oral tongue squamous cell carcinoma.	TLR9 TLR4	1.05e-05	2	113	2	32173390
Pubmed	Hierarchical self-assembly of amelogenin and the regulation of biomineralization at the nanoscale.	AMELX AMELY	1.05e-05	2	113	2	21825148
Pubmed	Amelogenin: a potential regulator of cementum-associated genes.	AMELX AMELY	1.05e-05	2	113	2	14653387
Pubmed	A synthetic, chemically modified ribozyme eliminates amelogenin, the major translation product in developing mouse enamel in vivo.	AMELX AMELY	1.05e-05	2	113	2	7489712
Pubmed	Baraitser-Winter cerebrofrontofacial syndrome.	ACTB ACTG1	1.05e-05	2	113	2	27625340
Pubmed	Controlled Osteogenic Differentiation of Mouse Mesenchymal Stem Cells by Tetracycline-Controlled Transcriptional Activation of Amelogenin.	AMELX AMELY	1.05e-05	2	113	2	26709694
Pubmed	Increased expression of Toll-like receptors 4 and 9 in human lung cancer.	TLR9 TLR4	1.05e-05	2	113	2	18763053
Pubmed	Comparison of body weight and gene expression in amelogenin null and wild-type mice.	AMELX AMELY	1.05e-05	2	113	2	16674684
Pubmed	Amelogenin-collagen interactions regulate calcium phosphate mineralization in vitro.	AMELX AMELY	1.05e-05	2	113	2	20404336
Pubmed	Identification of the functional activity of the [A-4] amelogenin gene splice product in newborn mouse ameloblasts.	AMELX AMELY	1.05e-05	2	113	2	18394981
Pubmed	A solution NMR investigation into the impaired self-assembly properties of two murine amelogenins containing the point mutations T21→I or P41→T.	AMELX AMELY	1.05e-05	2	113	2	23896516
Pubmed	Stage-Specific Role of Amelx Activation in Stepwise Ameloblast Induction from Mouse Induced Pluripotent Stem Cells.	AMELX AMELY	1.05e-05	2	113	2	34281250
Pubmed	The X-Y homologous gene amelogenin maps to the short arms of both the X and Y chromosomes and is highly conserved in primates.	AMELX AMELY	1.05e-05	2	113	2	1427830
Pubmed	Transgene animal model for protein expression and accumulation into forming enamel.	AMELX AMELY	1.05e-05	2	113	2	11063035
Pubmed	Regulation of amelogenin gene expression.	AMELX AMELY	1.05e-05	2	113	2	10200911
Pubmed	A human X-Y homologous region encodes "amelogenin".	AMELX AMELY	1.05e-05	2	113	2	2004775
Pubmed	Loss of biological control of enamel mineralization in amelogenin-phosphorylation-deficient mice.	AMELX AMELY	1.05e-05	2	113	2	35219810
Pubmed	Of mice and men: anatomy of the amelogenin gene.	AMELX AMELY	1.05e-05	2	113	2	2689082
Pubmed	Altering biomineralization by protein design.	AMELX AMELY	1.05e-05	2	113	2	16707492
Pubmed	Alveolar bone loss in relation to toll-like receptor 4 and 9 genotypes and Porphyromonas gingivalis carriage.	TLR9 TLR4	1.05e-05	2	113	2	27492306
Pubmed	Amelogenin supramolecular assembly in nanospheres defined by a complex helix-coil-PPII helix 3D-structure.	AMELX AMELY	1.05e-05	2	113	2	21984897
Pubmed	Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism.	NLGN4Y NLGN4X	1.05e-05	2	113	2	23183221
Pubmed	Elongation factor-2 kinase acts downstream of p38 MAPK to regulate proliferation, apoptosis and autophagy in human lung fibroblasts.	EEF2K MAPK1	1.05e-05	2	113	2	29355493
Pubmed	Juvenile manifestation of ultrasound communication deficits in the neuroligin-4 null mutant mouse model of autism.	NLGN4Y NLGN4X	1.05e-05	2	113	2	24855039
Pubmed	Cryogenic transmission electron microscopy study of amelogenin self-assembly at different pH.	AMELX AMELY	1.05e-05	2	113	2	21597263
Pubmed	Antisense inhibition of AMEL translation demonstrates supramolecular controls for enamel HAP crystal growth during embryonic mouse molar development.	AMELX AMELY	1.05e-05	2	113	2	8392462
Pubmed	Mobilization of TLR4 Into Lipid Rafts by Aggregatibacter Actinomycetemcomitans in Gingival Epithelial Cells.	TLR4 MAPK1	1.05e-05	2	113	2	27744428
Pubmed	Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder.	NLGN4Y NLGN4X	1.05e-05	2	113	2	37001827
Pubmed	An amelogenin mutation leads to disruption of the odontogenic apparatus and aberrant expression of Notch1.	AMELX AMELY	1.05e-05	2	113	2	20923441
Pubmed	Isolation of cDNA clones for mouse cytoskeletal gamma-actin and differential expression of cytoskeletal actin mRNAs in mouse cells.	ACTB ACTG1	1.05e-05	2	113	2	3221869
Pubmed	Helicobacter pylori regulates TLR4 and TLR9 during gastric carcinogenesis.	TLR9 TLR4	1.05e-05	2	113	2	25400780
Pubmed	Toll-like receptor gene polymorphisms are associated with susceptibility to Graves' ophthalmopathy in Taiwan males.	TLR9 TLR4	1.05e-05	2	113	2	21050493
Pubmed	TLR4 896A/G and TLR9 1174G/A polymorphisms are associated with the risk of infectious mononucleosis.	TLR9 TLR4	1.05e-05	2	113	2	32753695
Pubmed	Polymorphisms and haplotypes of TLR-4/9 associated with bacterial infection, gingival inflammation/recession and oral cancer.	TLR9 TLR4	1.05e-05	2	113	2	36563560
Pubmed	Protein interactions during assembly of the enamel organic extracellular matrix.	AMELX AMELY	1.05e-05	2	113	2	9041053
Pubmed	TLR4 and TLR9 polymorphism: Probable role in susceptibility among the population of Bihar for Indian visceral leishmaniasis.	TLR9 TLR4	1.05e-05	2	113	2	33910419
Pubmed	Expression of amelogenin in odontoblasts.	AMELX AMELY	1.05e-05	2	113	2	12667550
Pubmed	Spatial- and temporal-restricted pattern for amelogenin gene expression during mouse molar tooth organogenesis.	AMELX AMELY	1.05e-05	2	113	2	3253061
Pubmed	Isolation and characterization of a pseudoautosomal region-specific genetic marker in C57BL/6 mice using genomic representational difference analysis.	AMELX AMELY	1.05e-05	2	113	2	8618899
Pubmed	Polymorphisms and expression of TLR4 and 9 in malaria in two ethnic groups of Assam, northeast India.	TLR9 TLR4	1.05e-05	2	113	2	22948021
Pubmed	Influence of TLR4 and TLR9 polymorphisms and haplotypes on multiple hrHPV infections and HPV16 copy number in cervical cancer and cervicitis.	TLR9 TLR4	1.05e-05	2	113	2	34416273
Pubmed	Novel LRAP-binding partner revealing the plasminogen activation system as a regulator of cementoblast differentiation and mineral nodule formation in vitro.	AMELX AMELY	1.05e-05	2	113	2	31621902
Pubmed	Leucine rich amelogenin peptide alters ameloblast differentiation in vivo.	AMELX AMELY	1.05e-05	2	113	2	23747796
Cytoband	1q44	VN1R5 OR2T27 OR2T7 OR2T1 OR2T34 OR2T3	3.38e-07	110	113	6	1q44
Cytoband	Ensembl 112 genes in cytogenetic band chr1q44	VN1R5 OR2T27 OR2T7 OR2T1 OR2T34 OR2T3	8.26e-07	128	113	6	chr1q44
GeneFamily	Olfactory receptors, family 2	OR2A7 OR2T27 OR2T7 OR2T1 OR2T34 OR2T3 OR2A4	7.98e-07	113	82	7	149
GeneFamily	Actins	ACTB ACTG1 ACTG2	1.78e-06	6	82	3	929
GeneFamily	Solute carriers	SLC25A20 SLC13A3 SLC18B1 SLC5A5 SLCO2A1 SLC5A12 SLC14A2 SLC4A9	4.21e-04	395	82	8	752
GeneFamily	CD molecules\|Toll like receptors	TLR9 TLR4	8.93e-04	10	82	2	948
GeneFamily	Vomeronasal receptors	VN1R2 VN1R3 VN1R4 VN1R5	2.82e-03	129	82	4	291
GeneFamily	Aminoacyl tRNA synthetases, Class I	MARS1 VARS1	3.30e-03	19	82	2	131
GeneFamily	Carboxypeptidases	CPN2 CPVL	4.03e-03	21	82	2	1321
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	LAMB3 RALGAPA2 RYR3 SLC5A5 CLCN2 GALNT9 DNAH6 SEC14L1	3.25e-09	144	112	8	08005be9e3367f78ef27e125d9cce5ca53f4bd2d
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPRC5C PTCH1 RYR3 OIT3 CLCN2 DNAH6	6.98e-06	183	112	6	919c9861073d12fd12aecd7469b1478b13838c43
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CDK17 SNRK RALGAPA2 BMPR2 SLCO2A1 SEC14L1	1.00e-05	195	112	6	818bc18c5834238e5f733cac6fe928ed0788f57d
ToppCell	COVID-19-lung-Capillary_1\|lung / Disease (COVID-19 only), tissue and cell type	SNRK RALGAPA2 BMPR2 NLGN4X SLCO2A1 SEC14L1	1.06e-05	197	112	6	7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell	COVID-19-lung-Capillary_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CDK17 SNRK RALGAPA2 BMPR2 SLCO2A1 SEC14L1	1.09e-05	198	112	6	45419f2804b4be79bae6632e71c54e1af482d115
ToppCell	COVID-19-lung-Capillary_2\|lung / Disease (COVID-19 only), tissue and cell type	CDK17 SNRK RALGAPA2 BMPR2 SLCO2A1 SEC14L1	1.13e-05	199	112	6	793ce71b78a68033ef4419ed571e1dd86b40124f
ToppCell	LPS-IL1RA+antiTNF-Unknown-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC25A20 NLGN4Y ADCY3 RYR3 RUNDC1	2.10e-05	132	112	5	46c80eab16a70da9f363a9fbdf50bccab0b287d7
ToppCell	LPS-IL1RA+antiTNF-Unknown\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC25A20 NLGN4Y ADCY3 RYR3 RUNDC1	2.10e-05	132	112	5	a022c3c41654166cb106f27dc54fa88e8c40f898
ToppCell	kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LAMP2 SLC13A3 CPN2 SLC5A12 CPVL	3.30e-05	145	112	5	47a3bb973a508d3097213a2d86ad1ce697af9bae
ToppCell	LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NLGN4Y ACTG2 ADCY3 RYR3 RUNDC1	4.40e-05	154	112	5	16fdafb5c64d2db321554f87129a962d113f1668
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	KIF21B LMBRD2 TLR4 CCL4 MAP3K15	4.68e-05	156	112	5	c11ca6b1b5029c15aab91273cece70a487287839
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GPRC5C PTCH1 SYNGAP1 ZFYVE28 PZP	5.27e-05	160	112	5	79e833c904c762434993b5ec9d5e3540e695fad3
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LRRK1 RYR3 BMPR2 AHRR LOXL4	5.93e-05	164	112	5	d167c7a987b9b35d1e7725c803df4f9cd5380e47
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIF21B LRRK1 ADA2 XRN1 CPVL	6.46e-05	167	112	5	881f64db8dea3faa7588bf04d87c20924a4e5952
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Enterocyte_(Proximal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC25A20 LAMB3 SNRK CLCN2 SLCO2A1	7.23e-05	171	112	5	5d0d6c1ff610a703ae0b834a12823c5ff9012932
ToppCell	10x3'2.3-week_14-16-Myeloid_DC-DC-DC1\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ACTB AHRR BTN1A1 ADGRD2 CPVL	7.23e-05	171	112	5	459e1ac0b89571c39db98c0f578eca8f46caa8e3
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KIF21B NLGN4Y PTCH1 ABCA8 NLGN4X	7.84e-05	174	112	5	9c916af5eebd932f67dc9117e1d26ff194a2ff2c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KIF21B NLGN4Y PTCH1 ABCA8 NLGN4X	7.84e-05	174	112	5	bc71521f44a5fe013af42b06b5d1bd2446ecf3b5
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-4\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	SLC18B1 ABCA8 PLPPR4 TLR4 CACNA1I	8.06e-05	175	112	5	16849ea8f0985108baa2085f34c3de14a4f9f28b
ToppCell	Severe-CD4+_T_activated\|Severe / Disease group and Cell class	OR2A7 NLGN4Y TRIM22 XRN1 LONRF2	8.50e-05	177	112	5	a08f170f1143fcdd7d0842a54d9b807a4548f8b7
ToppCell	Severe-CD4+_T_activated\|World / Disease group and Cell class	OR2A7 NLGN4Y TRIM22 XRN1 LONRF2	8.73e-05	178	112	5	ef6111238703579a34bd6948bd9d4ca6b7e16063
ToppCell	renal_papilla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ACER2 LAMB3 CNNM1 LOXL4 SLC14A2	9.20e-05	180	112	5	49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DPPA2 ACTG1 SLC13A3 CCL4 PZP	9.44e-05	181	112	5	12ff56fa2949c8d53360cdf2cacfd326e65b54aa
ToppCell	P28-Endothelial-capillary_endothelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ACER2 ACTG1 SNRK BMPR2 SLCO2A1	1.07e-04	186	112	5	26a625ca0300055d6af3472aa0bfba59b73db292
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-3\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMB3 ZFYVE28 SLCO2A1 TLR4 DNAH6	1.07e-04	186	112	5	29c79b5a29907d4f3f87ad2ca04840c0f15b7d4e
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL4A6 NOXA1 LAMB3 GPRC5C ATP8A1	1.10e-04	187	112	5	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	Control-Endothelial_cells-Endothelial_cells_(general)\|Control / group, cell type (main and fine annotations)	RALGAPA2 BMPR2 NLGN4X SLCO2A1 SEC14L1	1.10e-04	187	112	5	fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMC7 LAMB3 LRRK1 SLC5A5 RUNDC1	1.10e-04	187	112	5	a6a112689d1c9049f57935ad9d2f4955538427de
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PTCH1 ATP8A1 ULBP1 CCL4 PZP	1.13e-04	188	112	5	f8e6247bedc0ba494c5bb551539cb8ba5a97f557
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PTCH1 ATP8A1 ULBP1 CCL4 PZP	1.13e-04	188	112	5	8155bc5476fc333bedcc78c5ddcc8e4912536caa
ToppCell	COVID-19-kidney-VWF+PLVAP+VCAM1+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ACER2 SNRK RYR3 SLCO2A1 SEC14L1	1.16e-04	189	112	5	c121817ddad164e9cfe382c43d0cbc9215508d02
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ACTB ACTG2 PTCH1 RYR3 PLPPR4	1.16e-04	189	112	5	b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f
ToppCell	T_cells-GZMK+_CD8+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	NLGN4Y ZFYVE28 ATP8A1 CCL4 PZP	1.16e-04	189	112	5	e2ca075aedf7c370ab4ede6272254ffd06cbcdec
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ACTG2 PTCH1 PLPPR4 SLCO2A1 AKAP1	1.16e-04	189	112	5	0abc7a4900cc9033bc1be69b770ccc54a6bf41b4
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(general)\|COVID-19 / group, cell type (main and fine annotations)	RALGAPA2 BMPR2 NLGN4X SLCO2A1 SEC14L1	1.19e-04	190	112	5	812e11314c76c0179fbe5a9bea29b41ce5cbc93d
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ACER2 CDK17 SNRK SLCO2A1 SEC14L1	1.22e-04	191	112	5	2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	CDK17 RALGAPA2 BMPR2 SLCO2A1 SEC14L1	1.22e-04	191	112	5	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	COPD-Lymphoid-T_Cytotoxic\|World / Disease state, Lineage and Cell class	CDK17 ZFYVE28 ATP8A1 CCL4 PZP	1.25e-04	192	112	5	5bfd9f5d47511441eb2d3cc3c4d7ed330ffd0bd1
ToppCell	IPF-Stromal-SMC\|Stromal / Disease state, Lineage and Cell class	COL4A6 ACTB ACTG2 GPRC5C AKAP1	1.25e-04	192	112	5	9b06c7336624ef21f8e5393725b56038a8028e57
ToppCell	COVID-19-Endothelial_cells-Inflamed_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	CDK17 SNRK RALGAPA2 SLCO2A1 SEC14L1	1.28e-04	193	112	5	979ebefa527f86bebeea5d94e626ee6c1cc7d53b
ToppCell	10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-basophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	KIF21B GPRC5C LMBRD2 RYR3 TEX101	1.31e-04	194	112	5	5da8873cddff582e5693b32fd3aaebc102f65fc0
ToppCell	facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACER2 SNRK BMPR2 SLCO2A1 SEC14L1	1.31e-04	194	112	5	f159ef8541d75a4e98468947f231bb463bec922c
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ACTB ACTG1 PTCH1 CCL4 MAPK1	1.31e-04	194	112	5	a8dc3336aa4ef497f6d26cede02ddac425e7c655
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CDK17 TMC7 RALGAPA2 BMPR2 SEC14L1	1.34e-04	195	112	5	d35102f95bb1e419d2df05ff0a01b6c5c923acef
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CDK17 RALGAPA2 BMPR2 SLCO2A1 SEC14L1	1.37e-04	196	112	5	7cbb19108b4553ef60ef5c230a29de1662c02efe
ToppCell	background-Endothelial_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	ACER2 CDK17 BMPR2 OIT3 SEC14L1	1.37e-04	196	112	5	e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CDK17 RALGAPA2 BMPR2 SLCO2A1 SEC14L1	1.37e-04	196	112	5	4cd1e6b7a791e11a40b19f971b7011bd11fe6273
ToppCell	COVID-19-lung-Capillary_Aerocytes\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SNRK RALGAPA2 BMPR2 SLCO2A1 SEC14L1	1.37e-04	196	112	5	49cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CDK17 RALGAPA2 BMPR2 SLCO2A1 SEC14L1	1.37e-04	196	112	5	d37f714d4fb57e958f3738fdda085560813e5bb5
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	ACER2 CDK17 SNRK SLCO2A1 SEC14L1	1.37e-04	196	112	5	b71b197cb92117dd9efaa13de000841901cc4ca8
ToppCell	367C-Fibroblasts-Fibroblast-K_(Pericytes)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	COL4A6 ACTB ACTG2 GPRC5C AKAP1	1.37e-04	196	112	5	1d94cecd378a829dd8014fc086d7fca48c953a91
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYO9B LAMP2 ADA2 TLR4 CPVL	1.37e-04	196	112	5	5fe6534af65d43eeacd4b031310242b4f706008b
ToppCell	COVID-19-lung-Capillary_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SNRK RALGAPA2 BMPR2 SLCO2A1 SEC14L1	1.37e-04	196	112	5	ac28e9be288af6f00a841aea4ce4b99aed6b4505
ToppCell	367C-Fibroblasts-Fibroblast-K_(Pericytes)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	COL4A6 ACTB ACTG2 GPRC5C AKAP1	1.37e-04	196	112	5	aacec48285bcb7ccf1b538187071885e3602cc49
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	SNRK RALGAPA2 BMPR2 SLCO2A1 SEC14L1	1.37e-04	196	112	5	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACER2 SNRK RALGAPA2 BMPR2 OIT3	1.40e-04	197	112	5	deefb492b5f0e6014144bd465c4a6ae4206e8739
ToppCell	Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	COL4A6 NOXA1 LAMB3 GPRC5C ATP8A1	1.40e-04	197	112	5	44a59dfb889577b3160a5b13ada1276771a00241
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACER2 SNRK RALGAPA2 BMPR2 OIT3	1.40e-04	197	112	5	a6aaa6faea348291023f0bc4b0f83fbc67d91da6
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL4A6 LAMB3 GPRC5C ATP8A1 AKAP1	1.40e-04	197	112	5	1485933986921ff45669d9b7501c8d17050b3e97
ToppCell	ASK452-Endothelial-Endothelium\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	CDK17 SNRK RALGAPA2 BMPR2 SLCO2A1	1.44e-04	198	112	5	e282769f5fa1765bcce79a0ed9d761bf2e14b012
ToppCell	CV-Severe-1\|CV / Virus stimulation, Condition and Cluster	ACTB ACTG1 TRIM22 CCL4 FLOT1	1.44e-04	198	112	5	fc0e885e370ffb780eada62bb2b52065c2f8b26b
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LONRF1 SNRK BMPR2 NLGN4X SEC14L1	1.44e-04	198	112	5	d5990cab01de6e6f3757f5a50ef70ced711bb1fa
ToppCell	LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells-mDC\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ACTB ACTG1 ABCC11 ADA2 CPVL	1.44e-04	198	112	5	d11097254791e415bf60a847feac81f400f11664
ToppCell	LPS_anti-TNF-Epithelial_alveolar\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NOXA1 LAMB3 GPRC5C ATP8A1 AKAP1	1.44e-04	198	112	5	53e9ed1b19cb26be58da0f37057caca0cdfaabeb
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACER2 SNRK RALGAPA2 BMPR2 OIT3	1.44e-04	198	112	5	f0f1816a0ed3ae8207442602f5cbe4de0382e4b3
ToppCell	facs-Tongue-nan-3m-Epithelial-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POLR2B LAMB3 LAMP2 MFSD14B MAPK1	1.47e-04	199	112	5	8d50e1ee58710d896c0204937331d9f4dcd38de0
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACTB ACTG1 LAMB3 GPRC5C SLC14A2	1.47e-04	199	112	5	56046a9f156d575c8810b7951043af471fb4c2ab
ToppCell	ASK452-Endothelial\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	CDK17 SNRK RALGAPA2 BMPR2 SLCO2A1	1.47e-04	199	112	5	0bc97a9a78aaafd1554ae6a61356ed9ea4983fa5
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SNRK RALGAPA2 TRIM22 BMPR2 SEC14L1	1.51e-04	200	112	5	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	Lung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SNRK RALGAPA2 BMPR2 SLCO2A1 SEC14L1	1.51e-04	200	112	5	e6d36be0c4c569e27303bb4e4f34cd2187e9759d
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SNRK RALGAPA2 TRIM22 BMPR2 SEC14L1	1.51e-04	200	112	5	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	mild-CD8+_Tem\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TRIM22 ATP8A1 XRN1 CCL4 PZP	1.51e-04	200	112	5	d8aec4904c9420b8f9d7508658ba1e36c66cdfcc
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SNRK RALGAPA2 TRIM22 BMPR2 SEC14L1	1.51e-04	200	112	5	2d07237022b409c4fac6fcf99b68c8affb3007cd
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	SNRK RALGAPA2 TRIM22 BMPR2 XRN1	1.51e-04	200	112	5	edb64556b3fefe3144f73b6efe23b9ffd34091d2
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SNRK RALGAPA2 TRIM22 BMPR2 SEC14L1	1.51e-04	200	112	5	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	Parenchyma_COVID-19-Endothelial-TX-Macrophages\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	SNRK RALGAPA2 BMPR2 SLCO2A1 SEC14L1	1.51e-04	200	112	5	c0c51719cf81512c50bfcc2fed883c867e522d2a
ToppCell	Lung_Parenchyma-Severe-Myeloid-Macrophage\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	SNRK RALGAPA2 BMPR2 SLCO2A1 SEC14L1	1.51e-04	200	112	5	758840c31f2ddd7ccf7bf13252ebb48d33e89479
ToppCell	Caecum-(1)_T_cell-(17)_gd_T\|Caecum / shred on region, Cell_type, and subtype	ACTB ACTG1 AHRR ATP8A1 MAPK1	1.51e-04	200	112	5	2aaa6b37e9f8d95de53f284a42a3ac14e6351b40
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ACTB LAMP2 ADA2 TLR4 CPVL	1.51e-04	200	112	5	bbe9597f8656f9652ba0c810fd962eaa434b3200
ToppCell	Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_capillary\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SNRK BMPR2 SLCO2A1 ULBP1 SEC14L1	1.51e-04	200	112	5	746e8f61411f8e68b988152ab36561991f716a0a
ToppCell	Caecum-T_cell-gd_T\|Caecum / Region, Cell class and subclass	ACTB ACTG1 AHRR ATP8A1 MAPK1	1.51e-04	200	112	5	eaacd14b6d4a1c7d52deab110ed3a6c7d3dc1f8e
ToppCell	Lung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	SNRK RALGAPA2 BMPR2 SLCO2A1 SEC14L1	1.51e-04	200	112	5	c37fe06a94e5779c56e01389869bb432d3bbaebc
ToppCell	(17)_gd_T\|World / shred on Cell_type and subtype	ACTB ACTG1 ATP8A1 CCL4 MAPK1	1.54e-04	201	112	5	7fcfe48758acf07cb3dda939ce589ae1518e41c9
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Col6a1_Fezf2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	POLE TLR9 NPC1L1	1.85e-04	44	112	3	2aa44b57544d5264db5b265ae60f7460c5b2a217
Disease	autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology)	ACTB ACTG1 ACTG2	2.15e-06	8	101	3	DOID:0110550 (implicated_via_orthology)
Disease	Baraitser-Winter syndrome 1 (implicated_via_orthology)	ACTB ACTG1 ACTG2	2.15e-06	8	101	3	DOID:0081112 (implicated_via_orthology)
Disease	Moyamoya disease (implicated_via_orthology)	ACTB ACTG1 ACTG2	2.15e-06	8	101	3	DOID:13099 (implicated_via_orthology)
Disease	thoracic aortic aneurysm (implicated_via_orthology)	ACTB ACTG1 ACTG2	2.15e-06	8	101	3	DOID:14004 (implicated_via_orthology)
Disease	intestinal atresia (implicated_via_orthology)	ACTB ACTG1 ACTG2	4.59e-06	10	101	3	DOID:10486 (implicated_via_orthology)
Disease	patent ductus arteriosus (implicated_via_orthology)	ACTB ACTG1 ACTG2	4.59e-06	10	101	3	DOID:13832 (implicated_via_orthology)
Disease	Colorectal Carcinoma	COL4A6 POLE LAMB3 TLR9 ABCA8 NLGN4X RPAP1 SLCO2A1 TLR4 LONRF2 PZP ANAPC4	5.17e-06	702	101	12	C0009402
Disease	amelogenesis imperfecta type 1E (implicated_via_orthology)	AMELX AMELY	1.16e-05	2	101	2	DOID:0110058 (implicated_via_orthology)
Disease	Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation	ACTB ACTG1	1.16e-05	2	101	2	C1855722
Disease	mastitis (biomarker_via_orthology)	TLR9 TLR4	1.16e-05	2	101	2	DOID:10690 (biomarker_via_orthology)
Disease	Baraitser-Winter syndrome	ACTB ACTG1	1.16e-05	2	101	2	cv:C1853623
Disease	Fryns-Aftimos Syndrome	ACTB ACTG1	1.16e-05	2	101	2	C1853623
Disease	sinusitis (is_marker_for)	TLR9 TLR4 CCL4	3.06e-05	18	101	3	DOID:0050127 (is_marker_for)
Disease	autosomal dominant hypocalcemia (biomarker_via_orthology)	AMELX AMELY	6.93e-05	4	101	2	DOID:0090109 (biomarker_via_orthology)
Disease	Uveoretinal Coloboma	ACTB ACTG1	2.41e-04	7	101	2	C4554007
Disease	Congenital ocular coloboma (disorder)	ACTB ACTG1	4.11e-04	9	101	2	C0009363
Disease	Congenital neurologic anomalies	ACTB ACTG1	5.13e-04	10	101	2	C0497552
Disease	cutaneous leishmaniasis (is_marker_for)	TLR9 TLR4	5.13e-04	10	101	2	DOID:9111 (is_marker_for)
Disease	pleural tuberculosis (is_marker_for)	ADA2 TLR4	5.13e-04	10	101	2	DOID:106 (is_marker_for)
Disease	dry eye syndrome (is_marker_for)	TLR4 CCL4	5.13e-04	10	101	2	DOID:10140 (is_marker_for)
Disease	Cranioschisis	ACTB ACTG1	5.13e-04	10	101	2	C0265541
Disease	allergic conjunctivitis (is_marker_for)	TLR9 TLR4	5.13e-04	10	101	2	DOID:11204 (is_marker_for)
Disease	myopathy (implicated_via_orthology)	COL4A6 ACTB CLCN2	6.02e-04	48	101	3	DOID:423 (implicated_via_orthology)
Disease	collagen disease (implicated_via_orthology)	COL4A6 TLR4	7.49e-04	12	101	2	DOID:854 (implicated_via_orthology)
Disease	asthma (is_marker_for)	TLR9 BMPR2 TLR4 CCL4	9.40e-04	126	101	4	DOID:2841 (is_marker_for)
Disease	allergic rhinitis (is_marker_for)	TLR9 TLR4	1.53e-03	17	101	2	DOID:4481 (is_marker_for)
Disease	dermatomyositis (is_marker_for)	TLR9 TLR4	1.53e-03	17	101	2	DOID:10223 (is_marker_for)
Disease	perinatal necrotizing enterocolitis (biomarker_via_orthology)	TLR9 TLR4	1.53e-03	17	101	2	DOID:8677 (biomarker_via_orthology)
Disease	Amelogenesis imperfecta	AMELX LAMB3	1.53e-03	17	101	2	cv:C0002452
Disease	autism spectrum disorder (implicated_via_orthology)	NLGN4Y SYNGAP1 NLGN4X MAPK1	1.88e-03	152	101	4	DOID:0060041 (implicated_via_orthology)
Disease	Lung Injury	TLR4 CCL4	2.33e-03	21	101	2	C0273115
Disease	Chronic Lung Injury	TLR4 CCL4	2.33e-03	21	101	2	C2350344
Disease	Septicemia	TLR4 MAPK1	3.05e-03	24	101	2	C0036690
Disease	Sepsis	TLR4 MAPK1	3.05e-03	24	101	2	C0243026
Disease	Severe Sepsis	TLR4 MAPK1	3.05e-03	24	101	2	C1719672
Disease	Pyemia	TLR4 MAPK1	3.05e-03	24	101	2	C0034189
Disease	lung squamous cell carcinoma (is_implicated_in)	POLE PTCH1	3.05e-03	24	101	2	DOID:3907 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
GAMLPPRLSLFCIAA	AHRR	261	A9YTQ3
FCIAAPVLLPSAAEM	AHRR	271	A9YTQ3
LFACLLGAAFAMPLP	AMELX	6	Q99217
ACVLGTIRPSFFLMP	ERV3-1	436	Q14264
LPSRFFCLLLGPCML	SLC4A9	261	Q96Q91
MAIQFRSLFPLALPG	AKAP1	1	Q92667
FAGSCLPRFSTMPFI	COL4A6	1511	Q14031
MLRVLPAGLFAHTPC	CPN2	276	P22792
LFACLVGAAFAMPLP	AMELY	6	Q99218
MLRFPTCFPSFRVVG	ANAPC4	1	Q9UJX5
LFFILPPICMCLFRQ	ACER2	41	Q5QJU3
MAVFPSSGLPRCLLT	BTN1A1	1	Q13410
RCPEALFQPSFLGME	ACTB	256	P60709
RCPEALFQPSFLGME	ACTG1	256	P63261
FRCPETLFQPSFIGM	ACTG2	256	P63267
TAMPPLTLGIFERSC	ATP8A1	901	Q9Y2Q0
APIARMFIFAILPDG	PZP	531	P20742
GIFPKCFVVPAGPRM	NOXA1	446	Q86UR1
PALMFSIPRLAIVCG	ZFYVE28	221	Q9HCC9
CILAEMLSNRPIFPG	MAPK1	216	P28482
GFLLTPITMSFPFCN	OR2T1	206	O43869
RVVCGMLGFPSEVPV	LOXL4	201	Q96JB6
MCPISAGSRPLEFFP	MAPK8IP3	616	Q9UPT6
FCGVPSPLRDMFPVR	LRRK1	1776	Q38SD2
SAPIRTPAMIGCSFV	GALNT9	316	Q9HCQ5
LCMRLFFEPVTTPCG	LONRF1	481	Q17RB8
LMLVAAFCSPALSAP	CCL4	11	P13236
SLVLLMPGPCDGLFR	CPVL	11	Q9H3G5
FCRSPPVMVAGGRVF	FLOT1	16	O75955
PVMVAGGRVFVLPCI	FLOT1	21	O75955
DGFLLTPVTMQFPFC	OR2T7	146	P0C7T2
MPPFLLLTCLFITGT	OIT3	1	Q8WWZ8
AFMLTLPFCGPNVID	OR4K13	161	Q8NH42
LAFIPGRPMLLSACR	KIF21B	1551	O75037
CPMSFFDTIPIGRLL	ABCC11	906	Q96J66
AAPIIGVTPMFAVCF	SLC25A20	76	O43772
MVCFRLFPVPGSGLV	LAMP2	1	P13473
LCMRLLFEPVTTPCG	LONRF2	451	Q1L5Z9
RDVPIFVCAMAFPTV	LONRF2	536	Q1L5Z9
GCIFFEMASGRPLFP	CDK17	376	Q00537
PFIFALCTIIPMEPD	POLE	476	Q07864
FFLPLLSRCPSAMGI	NFKBIL1	116	Q9UBC1
FPVGPRIQMLLFGLF	OR2A7	16	Q96R45
GFLLTPVTMQFPFCA	OR2T27	156	Q8NH04
GLLLTPITMSFPFCQ	OR2T34	161	Q8NGX1
GLLLTPITMSFPFCQ	OR2T3	161	Q8NH03
IFACLVPGFPAVMSS	RALGAPA2	151	Q2PPJ7
TVDMLQCLRFPGLAP	FAAP100	646	Q0VG06
FPVGPRIQMLLFGLF	OR2A4	16	O95047
ALVMCLGLPLFLFPG	GPRC5C	6	Q9NQ84
ICFFLGALTPMPAVR	NPC1L1	756	Q9UHC9
RDPSFLMGAARCLPL	MON1A	381	Q86VX9
VFGIPMIGPTELFSC	NLGN4Y	496	Q8NFZ3
PVTPRFIRHFSMLCL	DNAH6	2221	Q9C0G6
PMRVGDLGECFFPLS	CACNA1I	1896	Q9P0X4
IFMRCTDLFPGESVP	BMPR2	416	Q13873
GLPMCILGAFFGPIR	COQ4	191	Q9Y3A0
CLCLPRFMRLTFVPE	ADCY3	46	O60266
MLVDGPSERPALCFL	ADA2	1	Q9NZK5
MRPFFLLCFALPGLL	LAMB3	1	Q13751
RICESMGLAPFDLSP	EEF2K	316	O00418
CPITALGRTMATFPV	DHX37	766	Q8IY37
MAPARAGFCPLLLLL	RNASE7	1	Q9H1E1
IPGTVGCSFAFMLPV	SLC13A3	511	Q8WWT9
RFPTCPLIPMFVGSD	SEC14L1	26	Q92503
VFGIPMIGPTELFSC	NLGN4X	496	Q8N0W4
TVFFTCFPIPLMRIS	MFSD14C	116	Q5VZR4
TVFFTCFPIPLMRIS	MFSD14B	116	Q5SR56
RMISLFLLPACIFPS	DPPA2	256	Q7Z7J5
SPLPVFMLFLFIVGS	OR11G2	241	Q8NGC1
ATFLRGVLLMIPFPF	OR52N5	156	Q8NH56
ILPGFFCDLGPLMKV	OR1P1	186	Q8NH06
ILGPLCMPLVDRFIS	MAP3K15	216	Q6ZN16
LVMAPIACLLPAFSS	RUNDC1	451	Q96C34
TCLDVGLRLLSPFMP	VARS1	1051	P26640
ISKAPCMVLRLGFPI	SZT2	656	Q5T011
ELLLLPLSSFMPCGA	SFI1	1081	A8K8P3
GNFLPLCTFPLAVDM	RFPL1	16	O75677
DRVPDGPVFIAMCFL	SLC18B1	121	Q6NT16
FSGMLFCRLTPPLCL	LMBRD2	476	Q68DH5
SGIPIFMVLVPVFAL	SYNJ2BP	116	P57105
VTAFFMAALIPIPAL	PTCH1	556	Q13635
SMILGVCASIIPFPD	POLR2B	701	P30876
PVRCLFALSVPTLGM	OCSTAMP	101	Q9BR26
VLCPTVLMASLPFCG	OR6T1	156	Q8NGN1
PFGPVLCRLVMTLDG	SSTR5	106	P35346
LGVILFMLVCGQPPF	SNRK	201	Q9NRH2
TFLIPPATMIGCLFL	ABCA8	1166	O94911
MAPLGPAALLAVVRF	ADGRD2	421	Q7Z7M1
TIPVPCGAFMPVFVI	CLCN2	451	P51788
MAAAFPVCYPLGRLL	CNNM1	366	Q9NRU3
LCVPLFFMGCSTPTV	SLCO2A1	411	Q92959
PFLMLLSLAFAGPAI	PLPPR4	121	Q7Z2D5
RFLCPAIMSPSLFGL	SYNGAP1	596	Q96PV0
PLLGAFILGMFLPAC	SLC5A5	426	Q92911
FILGMFLPACNTPGV	SLC5A5	431	Q92911
AMTLALGTLPAFLPC	TLR9	21	Q9NR96
PDLFRMALPCLSAIA	RYR3	2556	Q15413
MATPLVAGPAALRFA	TINF2	1	Q9BSI4
LVHCMVFRFPGFPDL	USP35	376	Q9P2H5
GILAVGPMFVREACP	TEX101	196	Q9BY14
LSRICSLVGMPQPDF	XRN1	1446	Q8IZH2
LDRMSPFGSLVPVEC	THUMPD2	466	Q9BTF0
GNFLPLCTFPLAVDM	RFPL3	16	O75679
ALMSVCFPTLSPFVL	VN1R4	271	Q7Z5H5
PPAARLARLMCVFLV	RPAP1	1151	Q9BWH6
MFIGVIFCCTLRLPP	VN1R5	176	Q7Z5H4
MAAAASPAFLLCLPL	ULBP1	1	Q9BZM6
VASCVFLPRALALMP	WDR31	281	Q8NA23
IFATMPGLPGLFVAC	SLC5A12	326	Q1EHB4
ALITACFPMVSPFVL	VN1R3	271	Q9BXE9
LIPAMAFLSCVRPES	TLR4	11	O00206
LLFPVTFTAMSCPVL	SLC14A2	206	Q15849
AALANMLSVFGLPPC	SLC14A2	846	Q15849
VLTLFMAVPPCRIGV	TRIM22	431	Q8IYM9
MRLFVSDGVPGCLPV	MARS1	1	P56192
PGFEIRLTILRCVFM	TMC7	436	Q7Z402
IACFPTISPFVLMCR	VN1R2	356	Q8NFZ6
MSPGALAIIFAPCLL	MYO9B	1841	Q13459